However, in neuroblastoma cells, Y5R antagonists blocked the pro-survival effect mediated by BDNF (which favors NPY/Y5R expression/NPY release), promoted apoptosis, and sensitized resistant tumor cells to chemotherapy [10,185]. This evidence concerns the gene NPY and neuroblastoma.